bs-60217C [Life Science]
BAY 87-2243 --- Hypoxia-inducible Factor-1 (HIF-1) Inhibitor
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Formulation Powder

Storage: Store in dry, dark place at -20C for 1 year.

Product Information:

Molecular Weight: 525.53

Formula: C26 H26 F3 N7 O2

CAS Number: 1227158-85-1

InChi Key: CDJNNOJINJAXPV-UHFFFAOYSA-N

InChi: InChI=1S/C26H26F3N7O2/c1-17-14-22(25-31-24(33-38-25)19-2-6-21(7-3-19)37-26(27,28)29)32-36(17)16-18-8-9-30-23(15-18)35-12-10-34(11-13-35)20-4-5-20/h2-3,6-9,14-15,20H,4-5,10-13,16H2,1H3

Smiles: CC1=CC(=NN1CC1C=CN=C(C=1)N1CCN(CC1)C1CC1)C1=NC(=NO1)C1C=CC(=CC=1)OC(F)(F)F

Purity: 98.0

Solubility: DMSO up to 1 mM; EtOH up to 15 mM (heating)

Appearance: Solid Power.

Shelf Life: 1.0 years

Description:

BAY 87-2243 is a highly potent and selective inhibitor of hypoxia-induced gene activation, which has antitumor activities by inhibition of mitochondrial complex I. BAY 87-2243 mproves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. BAY-87-2243 markedly decreased nuclear HIF-1α expression and pimonidazole hypoxic fraction already after 3 days of drug treatment. BAY-87-2243 prior to RT significantly reduced TCD50 from 123 to 100 Gy (p=0.037). Additional BAY-87-2243 application during RT did not decrease TCD50.

Size: 2 mg solid, 10mg solid2 mg solid, 10mg solid

Applications: Life Science()

For research use only. Not intended for diagnostic or therapeutic use.